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6.1  Introduction 
 The diagnosis of allergic contact dermatitis is based on a positive diagnostic patch 
test combined with the patient’s history and the clinical pattern of the dermatitis. 
Contact allergy plays a role in about 35–40 % of patients with hand eczema [ 1 ]. 
Contact dermatitis is often a chronic and recurrent disease of multifactorial origin 
involving endogenous and exogenous factors. The choice of patch test allergens to 
be tested in a patient with suspected allergic contact dermatitis is crucial – for both 
occupationally and nonoccupationally related contact dermatitis. The correct diag-
nosis of allergic contact dermatitis may be missed if the allergen in question is not 
tested. The failure of diagnosing a contact allergy may have legal implications for 
occupationally related contact dermatitis and may affect the advice to the patient, 
the treatment, and prognosis of the eczema. The fact that allergic contact dermatitis 
is often a complicating factor aggravating other eczematous diseases adds to the 
uncertainty. 
 An experienced dermatologist may guess correctly the clinically important con-
tact allergy in some patients. The guess may sometimes be correct for common 
allergens as nickel and is much more often incorrect for less common allergens 
(<10 %) [ 1 – 3 ]. 
 The use of a baseline patch test series comprising the most common allergens in 
all patients with suspected allergic contact dermatitis is widely accepted. The base-
line series may vary from clinic to clinic depending on what the population is exposed 
to, which may differ between geographic regions, the industrial development, and 
common occurrence of various professions and consumer goods and habits. 
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 However, supplementary tests with working materials, properly diluted, and 
extra allergens selected on the basis of patient history and known exposures are 
often required to assure the correct diagnosis. It is mandatory to carefully consider 
the choice of patch test concentration and vehicle when testing with materials that 
are not standardized [ 4 ]. 
 A survey from four university clinics showed that 5–23 % of the patients in dif-
ferent clinics had contact allergies to compounds outside the former European stan-
dard series only [ 5 ]. If contact allergies are diagnosed early and early intervention 
is carried out, the prognosis may be better [ 6 ]. 
 According to de Groot’s monograph on patch testing [ 7 ], there are at least 4,350 
known contact allergens. Every year, new chemicals are added to the list as possible 
contact allergens. Most clinics have available only a few allergens beyond the base-
line series, and only dermatology departments with a special interest in contact 
dermatitis have a big selection of extra contact allergens available for routine use 
when indicated. 
6.2  Supplementary Patch Test Allergens 
 These extra allergens may be purchased from the commercial patch test material suppli-
ers (e.g., TROLAB Almirall Hermal GmbH, in Reinbek, Germany; Chemotechnique, in 
Vellinge, Sweden; and allergEAZE, SmartPractice, in Calgary, Canada), or the raw 
material may be acquired from different sources and made up in petrolatum in the proper 
patch test concentration at a pharmacy. The commercial patch test materials have a lim-
ited shelf life. Each syringe is labeled with a date of expiration, which varies between 
substances. Some have a short shelf life due to evaporation or chemical change (i.e., 
oxidation). Special allergens may be acquired from industry, chemical suppliers, manu-
facturers, and workplaces and need preparation in appropriate concentration and in an 
appropriate vehicle before they can be used for testing patients. 
 A crucial point is how to select extra allergens for the individual patient. Here, it 
is important to ask the patient to bring to the clinic safety data sheets of working 
materials, labels from working material containers with information about ingredi-
ents, and contact information for the manufacturer. Based on this information 
together with the patient history and interview, it is possible to trace exposure to 
chemicals and substances that are potential contact allergens. 
 An important exposure source is the topical remedies used by the patient at home 
and at work (i.e., all cosmetics, skin care products, gloves, and other protective 
gear). Testing with products used at home and at work often gives positive patch test 
reactions of importance for evaluation of the patient’s dermatitis [ 8 ,  9 ]. 
6.3  The Allergen Bank 
 Rare allergens may also be acquired from an “allergen bank.” This is an option in 
certain countries [ 10 ,  11 ] ( www.allergenbanken.dk ). The basic idea is to make 
available to dermatologists in private practice extra allergens, which he/she can 
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order from the “bank” for specifi c testing of individual patients guided by the expo-
sure history, obtained either through job description and the dermatologist’s specifi c 
knowledge of allergen exposure or through evaluation of safety data sheets. 
 The allergen bank contains four separate parts:
 1.  A “bank,” which is a refrigerator with about 400–500 numbered contact aller-
gens obtained from commercial suppliers, product manufacturers, and pharma-
cies. The contact allergens are most often prepared in petrolatum and kept in 
polypropylene syringes in darkness at 4 °C. A few allergens are stored in bottles 
in appropriate vehicles and others in the freezer due to stability concerns. 
 2.  A list of available contact allergens divided into appropriate series or lists of 
allergens from which the dermatologist can select extra allergens for an indi-
vidual patient. The list is available to the dermatologist subscribing to the service 
in a booklet and on the password-protected website. The list is updated regularly 
and contains information about the source of the allergen, concentration and 
vehicle, CAS number when available, and other relevant information where 
appropriate (i.e., INCI names and synonym names). 
 3.  A mailing system, so the contact allergens ordered from a dermatologist for a 
specifi c patient can be mailed shortly before scheduled patch testing in order to 
counteract stability problems present for volatile contact allergens as fragrance 
chemicals and acrylates [ 12 ,  13 ]. The allergens are shipped in plastic chambers 
with a lid (i.e., IQ chamber [Chemotechnique Diagnostics, Vellinge, Sweden]) or 
for volatile allergens in Van der Bend transport containers (Van der Bend BV, 
Brielle, the Netherlands), and it is highly recommended that the allergens are 
kept in a refrigerator until use. 
 4.  A database, to register allergens, subscribing dermatologists, patch- tested patients, 
and the outcome of the tests. The subscribing dermatologist is obliged to supply 
relevant information for each patient tested with allergens ordered from the aller-
gen bank. It encompasses personal identifi cation number, age, sex, MOAHLFA 
index, and scheduled date for testing, and to send back to the allergen bank the 
result of the patch test procedure. Information about the relevance of the positive 
patch tests is also recorded when available. The program also contains a statistical 
package that makes it possible to extract patch test data in various ways according 
to research questions and quality control. 
 In Denmark, the allergen bank service supplying “rare” allergens to dermatolo-
gists, on a case-by-case basis, was established in 1992 [ 10 ,  11 ]. A similar service has 
been established in Australia [ 14 ], the Contact Allergen Bank Australia ( http://www.
occderm.asn.au/projects.html ), and in the Netherlands (T. Rustemeyer, personal 
information, 2014). The extent of service and the organization of an allergen bank 
service depend on the organization of the local health care system in each country. 
Such a service carries advantages and also challenges, as pointed out in Table  6.1 .
 An allergen bank is a pragmatic tool for dermatologists interested in contact 
dermatitis, and the value of the “tool” is, of course, dependent on how it is used. The 
Danish Allergen Bank only accepts subscription from certifi ed dermatologists in 
the country, and they are all to varying degrees trained in diagnostic patch testing. 
The interested and knowledgeable dermatologist can use the allergen bank service to 
provide optimal clinical evaluation and testing of contact dermatitis patients without 
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having all relevant environmental contact allergens in stock in the clinic – and avoid 
referring these patients to another clinic. Other dermatologists may choose to omit 
testing beyond the baseline series and refer more “problematic” contact dermatitis 
patients to a tertiary center with the expertise and allergens available. The question 
arises: Who has the knowledge and experience required and who does not? That can 
be debated. 
 In Denmark about half of the dermatologists in private practice subscribe to the 
allergen bank. 
 Recently, two publications with data from the allergen bank service have been 
published. They report how dermatologists in private practice have identifi ed 
patients with important and relevant contact allergies to thiourea compounds and to 
octylisothiazolinone [ 15 ,  16 ]. Some of these patients may have escaped diagnosis, 
information, and advice if the allergens had not been available through the bank 
service – or perhaps they would have been referred to a tertiary center, with the 
waiting time and overall expenses attached to the extra test procedures. 
 About 900–1,000 patients a year are tested with allergens ordered from the 
Danish Allergen Bank and a total of about 14,000–15,000 patch tests are mailed to 
the clinics, giving an estimated average of 14–15 allergens per patient. Most aller-
gens are tested as part of a supplementary series, and about 15–20 % are ordered as 
single allergens for aimed testing of a specifi c patient. 
 The value of an allergen bank is, of course, questionable, and critics argue that 
the contact dermatitis patients are better off being referred to a tertiary center with 
more experience and “all” contact allergens available. The limitations for this 
 Table 6.1  The allergen bank: advantages and challenges 
 Advantages 
 Extra allergens are easily available for the dermatologist. 
 The patient may avoid referral to other clinic and thereby save time. 
 Improved diagnosis of contact allergy is possible. 
 More detailed testing and advice may improve prognosis of the dermatitis. 
 Occupational cases may be notifi ed more carefully, and this may affect legal compensation. 
 Detection of “new” allergens in the environment is possible. 
 More experience with rare allergens, levels of test concentration, and level of irritancy. 
 The easy access to extra allergens makes diagnostic testing more rewarding for the 
dermatologist. 
 The service may be used as a quality control of patch test activity in the clinic. 
 The database included in the allergen bank is a research tool. 
 Challenges 
 The dermatologist should obtain an adequate patient history of exposure. 
 Relevant allergens should be ordered. 
 What is most effi cient for optimal evaluation of the individual patient – testing with extra series 
of allergens based on exposure history or aimed testing with selected allergens based on 
exposure analysis? 
 Quality of allergens – regular renewal of patch test material is required. 
 Test results should be returned to the allergen bank for inclusion in the database. 
 Economy – annual subscription fee (600 €/year in Denmark) or payment per patch test. 
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opinion include, among other factors, waiting time, transport, more days off work, 
extra test procedures, and capacity at the tertiary center. The proponents for an aller-
gen bank argue that contact dermatitis is an important subspecialty in dermatology, 
and dermatologists in practice should be able to perform diagnostic patch testing on 
a level beyond using a baseline series. In this case, an allergen bank is a pragmatic 
solution that gives the dermatologist access to extra allergens without keeping them 
in stock at the clinic. Many supplementary series are used rarely, and the allergens 
may soon reach the expiration date listed on the syringe. The allergen bank can 
deliver “fresh” allergens. 
 Further, the collection of patch test results in the database becomes an impor-
tant source of information for clinical research. When the allergen bank service is 
in use in clinics around the country, it gives dermatologists an opportunity to 
discover new “small epidemics” of special contact allergies before they are per-
ceived at the tertiary centers. It is the author’s opinion that the allergen bank has a 
pedagogic  infl uence, making the dermatologists in practice more interested in 
contact dermatitis – “it becomes professionally more rewarding to investigate 
contact dermatitis patients and to fi nd the relevant allergies.” 
6.4  Information About Rare Allergens 
 Information about rare allergens can be obtained from the contact dermatitis text-
books. Further information can be obtained from valuable databases on the Internet 
such as PubMed and many others (see Table  6.2 ).
 Further, An Goossens, Department of Dermatology, K.U. Leuven, Belgium, has 
developed the CDESKPRO website –  http://www.cdeskpro.be – available to regis-
tered users with a large amount of information on allergens, topical pharmaceutical 
products, lists of cosmetic products not containing the specifi c allergens, literature 
references, and useful links. The website is available in English, French, and Dutch. 
Other national websites include the national contact dermatitis research groups and 
the European Contact Dermatitis Society ( http://www.ESCD.org ). 
 A simple, effi cient approach sometimes is just to search the name of substance or 
the CAS number, when available, in Google or a similar search engine, and this will 
lead you to information about the chemicals in question. The international hazard 
data sheets on occupation give relevant information about the different hazards 
associated with special occupations. The International Clinical Safety Cards (ICSC) 
lead you to other databases where you can trace information. Composition of vari-
ous protective clothing and gloves can also be found on the Internet (see Table  6.2 ). 
 It is important to realize that the intention and quality of information are very 
different from website to website. 
 These activities may be time-consuming, but they are very important for an opti-
mal outcome of the evaluation, advice, and treatment of contact dermatitis cases. 
 The websites from the patch test material suppliers are also useful and updated 
on a regular basis. 
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 Searching can be time-consuming but is often worthwhile both for yourself and 
for your patients. With more training, you develop search strategies, which will ease 
your work. 
6.5  “Difficult Allergens” 
 Chemical substances with a patch test concentration close to the irritant threshold 
concentration are diffi cult to test with because they may cause a high frequency of 
doubtful positive reactions, which may be a sign of irritancy or a weak positive 
allergic reaction. Emulsifi ers, some biocides, and fragrance chemicals are examples 
of diffi cult allergens [ 17 ,  18 ]. When reading patch tests, it is often not possible to 
differentiate between a weak positive allergic reaction and an irritant reaction. In 
these cases, repeated patch tests, tests with a dilution series, late readings, and a 
careful exposure history may be helpful. These “diffi cult allergens” may also give 
rise to considerable variation between results from different clinics around the 
world. This variation may be partly explained by differences in scoring practices 
between dermatologists. In this context, it is important to acknowledge that diag-
nostic patch testing is just a tool for the dermatologist, with inherent pitfalls and 
variation due to several factors such as technical details, scoring of test results, and 
 Table 6.2  Selected websites for retrieving information about chemicals and products to which a 
dermatitis patient is exposed 
 PubMed  http://www.ncbi.nlm.nih.gov/pubmed 
 Safety datasheets may be retrieved from the Web, for example 
 In German  http://www.wingis-online.de/wingisonline/ 
 In English  http://www.ilo.org/dyn/icsc/showcard.home 
 Other comprehensive sources of information 
 The European Commission database with 
information on cosmetic ingredients 
 http://ec.europa.eu/consumers/sectors/cosmetics/
cosing/ 
 NIOSH Pocket Guide to Chemical Hazards  http://www.cdc.gov/niosh/topics/chemical.html 
 Occupational Health Guidelines for 
Chemical Hazards 
 http://www.cdc.gov/niosh/topics/default.html 
 The German Institute of Occupational 
Safety and Health 
 http://www.dguv.de/ifa/en/index.jsp 
 List of allergens in protective gloves  http://www.bgbau.de/gisbau/service/allergene/
allergeneliste-nach-hersteller-1 
 Environmental Health and Toxicology  http://sis.nlm.nih.gov/enviro.html 
 ChemIDplus contains information on 
chemistry and toxicity for 370,000 
substances 
 http://chem.sis.nlm.nih.gov/chemidplus/
chemidlite.jsp 
 Certain databases require subscription for access to the information 
 ChemKnowledge  http://www.rightanswer.com/index.php/
knowledge-solutions/chemknowledge- system/
tomes-plus-system 
 CDESKPRO  http://www.cdeskpro.be/fi les/opties_e.htm 
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interindividual variation between patients and between dermatologists and that pos-
itive test results are not in themselves a result of current signifi cant relevance with-
out a thorough evaluation of the compound in question and the patient’s history 
together with the clinical picture of the patient’s dermatitis. 
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 Practical Tips 
•  Contact allergy to substances beyond the baseline series is common. 
•  Knowledge about exposure scenarios in various professions is important. 
•  Safety data sheets for chemicals and list of ingredients in products are very 
helpful. 
•  Guessing a patient’s contact allergy is useless; testing is needed. 
•  Patch test the patient with selected working material, topical remedies 
used, and protective gloves. 
•  Rare allergens may be acquired from commercial patch test suppliers, 
industry, manufacturers, or an allergen bank. 
•  The Internet offers a multitude of useful information databases. 
•  “Diffi cult allergens” are those with a patch test concentration close to the 
irritancy threshold (i.e., emulsifi ers, some biocides, and fragrance 
chemicals). 
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